Abstract
Previously it was shown that human interleukin 1 (huIL-1) and a huIL-1 fragment, huIL-1 beta 208-240, are somnogenic and pyrogenic in rabbits. However, the amino acid sequences for IL-1 are species-specific and it was unknown whether rabbit (rb) IL-1 beta 208-240 and rat (rt) IL-1 beta 208-240 were active in their respective species. Furthermore, it was unknown whether these fragments elicited their effects via the IL-1 receptors. Two doses of rbIL-1 beta 208-240 (6.0 and 12.0 nmol) were intracerebroventricularly administered to rabbits. The 6.0-nmol dose had little effect, whereas the 12.0-nmol dose greatly increased non-rapid-eye-movement sleep across a 6-hr recording period and induced a febrile response. Rats injected intracerebroventricularly with rtIL-1 beta 208-240 at dark onset responded to three doses of the peptide (1.2, 2.4, and 4.8 nmol). The 1.2-nmol dose did not greatly affect sleep but did induce a moderate febrile response. The 2.4- and 4.8-nmol doses increased non-rapid-eye-movement sleep across the 12-hr recording period. Maximal brain temperature elevations relative to controls after the 2.4- and 4.8-nmol doses of the peptide were 0.9 +/- 0.2 degrees C and 0.7 +/- 0.2 degrees C, respectively. These responses in both rabbits and rats were completely blocked or significantly attenuated when the animals were pretreated with an IL-1 receptor antagonist. These results suggest that the biological activities of IL-1 beta 208-240 are mediated via the IL-1 beta receptors.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Antoni G., Presentini R., Perin F., Tagliabue A., Ghiara P., Censini S., Volpini G., Villa L., Boraschi D. A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol. 1986 Nov 15;137(10):3201–3204. [PubMed] [Google Scholar]
- Boraschi D., Tagliabue A. Structure-function relationship of interleukin-1 giving new insights for its therapeutic potential. Biotherapy. 1989;1(4):377–389. doi: 10.1007/BF02171014. [DOI] [PubMed] [Google Scholar]
- Dinarello C. A., Ikejima T., Warner S. J., Orencole S. F., Lonnemann G., Cannon J. G., Libby P. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol. 1987 Sep 15;139(6):1902–1910. [PubMed] [Google Scholar]
- Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
- Eisenberg S. P., Evans R. J., Arend W. P., Verderber E., Brewer M. T., Hannum C. H., Thompson R. C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990 Jan 25;343(6256):341–346. doi: 10.1038/343341a0. [DOI] [PubMed] [Google Scholar]
- Epstein A. N., Fitzsimons J. T., Rolls B. J. Drinking induced by injection of angiotensin into the rain of the rat. J Physiol. 1970 Sep;210(2):457–474. doi: 10.1113/jphysiol.1970.sp009220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990 Jan 25;343(6256):336–340. doi: 10.1038/343336a0. [DOI] [PubMed] [Google Scholar]
- Krueger J. M., Obal F., Jr, Opp M., Toth L., Johannsen L., Cady A. B. Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med. 1990 Mar-Apr;63(2):157–172. [PMC free article] [PubMed] [Google Scholar]
- Lue F. A., Bail M., Jephthah-Ochola J., Carayanniotis K., Gorczynski R., Moldofsky H. Sleep and cerebrospinal fluid interleukin-1-like activity in the cat. Int J Neurosci. 1988 Oct;42(3-4):179–183. doi: 10.3109/00207458808991595. [DOI] [PubMed] [Google Scholar]
- Moldofsky H., Lue F. A., Davidson J. R., Gorczynski R. Effects of sleep deprivation on human immune functions. FASEB J. 1989 Jun;3(8):1972–1977. doi: 10.1096/fasebj.3.8.2785942. [DOI] [PubMed] [Google Scholar]
- Obal F., Jr, Opp M., Cady A. B., Johannsen L., Postlethwaite A. E., Poppleton H. M., Seyer J. M., Krueger J. M. Interleukin 1 alpha and an interleukin 1 beta fragment are somnogenic. Am J Physiol. 1990 Sep;259(3 Pt 2):R439–R446. doi: 10.1152/ajpregu.1990.259.3.R439. [DOI] [PubMed] [Google Scholar]
- Opp M. R., Krueger J. M. Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever. Am J Physiol. 1991 Feb;260(2 Pt 2):R453–R457. doi: 10.1152/ajpregu.1991.260.2.R453. [DOI] [PubMed] [Google Scholar]
- Opp M. R., Obal F., Jr, Krueger J. M. Interleukin 1 alters rat sleep: temporal and dose-related effects. Am J Physiol. 1991 Jan;260(1 Pt 2):R52–R58. doi: 10.1152/ajpregu.1991.260.1.R52. [DOI] [PubMed] [Google Scholar]
- Opp M., Obál F., Jr, Krueger J. M. Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol. 1989 Sep;257(3 Pt 2):R528–R535. doi: 10.1152/ajpregu.1989.257.3.R528. [DOI] [PubMed] [Google Scholar]
- Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987 Oct 23;238(4826):522–524. doi: 10.1126/science.2821621. [DOI] [PubMed] [Google Scholar]
- Toth L. A., Krueger J. M. Alteration of sleep in rabbits by Staphylococcus aureus infection. Infect Immun. 1988 Jul;56(7):1785–1791. doi: 10.1128/iai.56.7.1785-1791.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toth L. A., Krueger J. M. Effects of microbial challenge on sleep in rabbits. FASEB J. 1989 Jul;3(9):2062–2066. doi: 10.1096/fasebj.3.9.2663582. [DOI] [PubMed] [Google Scholar]